Chris A. Rallis, Director at FENNEC PHARMACEUTICALS INC. (FENC), sold 1,119 shares at $8.71 ($10K) on 2025-07-07, disclosed to the SEC on 2025-07-07.
Scheduled sale ($10k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| FENC | SELL | 2025-04-11 | $7K | — | Filing → |
| FENC | SELL | 2025-02-14 | $8K | — | Filing → |
| FENC | SELL | 2024-12-02 | $39K | — | Filing → |